Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians.
The optimal perioperative anticoagulation management in patients on warfarin therapy is poorly defined because of the lack of randomized trials. Because guidelines are heterogeneous, we hypothesized that treatment strategies are not uniform in clinical practice. During the Annual Meeting of the Italian Federation of Anticoagulation Clinics, a questionnaire with four different clinical scenarios was distributed. Two scenarios described the cases of patients with a mechanical heart valve in the mitral position and additional risk factors for systemic embolism, one undergoing major surgery (case 1) and one undergoing minor surgery (case 3). Two scenarios described patients with an aortic mechanical heart valve, one undergoing major surgery (case 2) and one minor surgery (case 4). Different preoperative and postoperative management options were offered. Treatment options for all scenarios were the same. Of the 300 questionnaires distributed, 72 were returned (24%). Outpatient full-dose low molecular weight heparin (LMWH) was the most selected strategy in the preoperative phase. It was chosen by 90.3% of participants in case 3, 87.5% in case 1, 62.5% in case 2, and 52.8% in case 4. In the postoperative phase, full-dose LMWH remained the most selected option for cases 1 (75%) and 3 (70.8%), whereas low-dose LMWH was selected by the majority for cases 2 (50%) and 4 (61.1%). Even among expert clinicians, the management of perioperative anticoagulation is heterogeneous. In particular, the definition of risk categories and the optimal intensity of antithrombotic drugs remain to be assessed by well-designed prospective studies.
Ageno
Walter
W
Thrombosis Unit, Department of Internal Medicine, University of Insubria, Varese, Italy. agewal@yahoo.com
Garcia
David
D
Libby
Edward
E
Crowther
Mark A
MA
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001021:Aortic Valve; D003625:Data Collection; D017558:Elective Surgical Procedures / Q000379:methods*; D006282:Health Personnel; D006350:Heart Valve Prosthesis; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008943:Mitral Valve; D019990:Perioperative Care / Q000379:methods; D012307:Risk Factors
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight